BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Latest Pharma Insights



The Harsh Light Of Hard Facts: Valuing Pharma In A Made For Measure World
With a challenging new decade of scientific discovery looming, 2019 is the positioning year for biopharma to make value, transparency...
Scrip - December 12, 2018
The Harsh Light Of Hard Facts: Valuing Pharma In A Made For Measure World
With a challenging new decade of scientific discovery looming, 2019 is the positioning year for biopharma to make value, transparency...
IN VIVO - December 12, 2018
HRA Pharma Reveals Big Growth Ambitions In Quest To Become Top-10 OTC Player
A combination of prescription-to-OTC switches, acquisitions and maximising the potential of its existing portfolio will take France’s HRA Pharma to...
The Rose Sheet - December 12, 2018
Executives On The Move: New Hires at Omeros and Theratechnologies Plus Promotions at Alimera and Constellation
Omeros gains a new head of commercial and a VP of CMC from Celgene, while Alimera Sciences promotes its president to CEO and Constellation Pharma moves...
Scrip - December 12, 2018
Pilots Between NHS And Pharma Finally Take Off
The majority of pharmaceutical companies in the UK work closely with the NHS and In Vivo spoke to one of them –...
Scrip - December 12, 2018
Pilots Between NHS And Pharma Finally Take Off
The majority of pharmaceutical companies in the UK work closely with the NHS and In Vivo spoke to one of...
IN VIVO - December 12, 2018
CarThera Secures First VC Investment To Run Pivotal Study Of Glioblastoma Therapy
CarThera has secured its first financial round from institutional investors to launch a pivotal trial evaluating the company's Sonocloud ultrasound...
Medtech Insight - December 12, 2018
Japan Pharma Climbing Aboard Digital Health Train, But Not Up To Speed?
The still somewhat loosely defined concept of 'digital health' continues to take concrete forms through recent deals in Japan, where...
Scrip - December 12, 2018

The Harsh Light Of Hard Facts: Valuing Pharma In A Made For Measure World
With a challenging new decade of scientific discovery looming, 2019 is the positioning year for biopharma to make value, transparency...
Scrip - December 12, 2018
Executives On The Move: New Hires at Omeros and Theratechnologies Plus Promotions at Alimera and Constellation
Omeros gains a new head of commercial and a VP of CMC from Celgene, while Alimera Sciences promotes its president to CEO and Constellation Pharma moves...
Scrip - December 12, 2018
Pilots Between NHS And Pharma Finally Take Off
The majority of pharmaceutical companies in the UK work closely with the NHS and In Vivo spoke to one of them –...
Scrip - December 12, 2018
Japan Pharma Climbing Aboard Digital Health Train, But Not Up To Speed?
The still somewhat loosely defined concept of 'digital health' continues to take concrete forms through recent deals in Japan, where...
Scrip - December 12, 2018

Infectious Diseases Proposed As Focus Of Inter-Korea Health Cooperation
Amid ongoing talks to denuclearize North Korea, the two Koreas are gearing up for bilateral cooperation in various industries including...
The Pink Sheet - December 11, 2018
Medicare Part D ‘Enhanced MTM Model’ Saves $325m In First Year
US Centers for Medicare and Medicaid Services announces first-year results from its medication therapy management model, intended to optimize prescription...
The Pink Sheet - December 11, 2018
When Drugs Become Biologics: US FDA Guidances Explain 'Transition Provisions'
With two new guidance documents, agency is trying to bring order to the potentially chaotic regulatory process that insulins and...
The Pink Sheet - December 11, 2018
US FDA's Gottlieb Shuts The Door On Exclusivity For 'Transition' Biologics
With an eye toward interchangeable insulins, FDA commissioner says existing protein products that will be 'deemed to be licensed' as...
The Pink Sheet - December 11, 2018
CHMP Meeting Under Way: Who Will Pass Muster This Month?
With its final meeting of the year under way, the EMA's medicines evaluation committee, the CHMP, will bring seasonal cheer...
The Pink Sheet - December 11, 2018
CHMP Delays Review of Portola's Ondexxya; Who Will Pass Muster?
With its final meeting of the year under way, the EMA's medicines evaluation committee, the CHMP, will bring seasonal cheer...
The Pink Sheet - December 11, 2018
Brexit Delays Key ATMP Guideline Update – EMA Says Perhaps Not So Bad
The European Medicines Agency's proposal to revise its decade-old guideline on safety and efficacy follow-up and risk management of advanced...
The Pink Sheet - December 11, 2018
Revamped Cancer Drugs Fund Means More Positive Recommendations, Says NICE
NICE, the health technology appraisal body for England and Wales, has rejected criticism that access to cancer drugs is worsening...
The Pink Sheet - December 11, 2018
EMA Set For More Staff Losses & Activity Cuts Next Year
The latest EMA management board meeting heard an update on the situation regarding Brexit-related staff losses and recruitment, and was...
The Pink Sheet - December 11, 2018
US Court Says J&J Must Face Majority Of Purchasers’ Remicade Antitrust Suit
Purchasers of the Remicade infliximab brand in the US have accused Johnson & Johnson of an antitrust scheme effectively precluding...
The Pink Sheet - December 11, 2018
US Court of Appeals Upholds Gilenya Compound Patent, Dealing A Blow To Ezra Ventures
Upholding the validity of Novartis’ Gilenya compound patent, a US Court of Appeals ensures that US-based Ezra’s generic fingolimod hydrochloride...
The Pink Sheet - December 11, 2018
Akorn's Chief Steps Down After Losing Kabi Deal
Akorn is seeking a new CEO after current head Raj Rai announced plans to retire, as a US Supreme Court...
The Pink Sheet - December 11, 2018

The Harsh Light Of Hard Facts: Valuing Pharma In A Made For Measure World
With a challenging new decade of scientific discovery looming, 2019 is the positioning year for biopharma to make value, transparency...
IN VIVO - December 12, 2018
Pilots Between NHS And Pharma Finally Take Off
The majority of pharmaceutical companies in the UK work closely with the NHS and In Vivo spoke to one of...
IN VIVO - December 12, 2018

CarThera Secures First VC Investment To Run Pivotal Study Of Glioblastoma Therapy
CarThera has secured its first financial round from institutional investors to launch a pivotal trial evaluating the company's Sonocloud ultrasound...
Medtech Insight - December 12, 2018

HRA Pharma Reveals Big Growth Ambitions In Quest To Become Top-10 OTC Player
A combination of prescription-to-OTC switches, acquisitions and maximising the potential of its existing portfolio will take France’s HRA Pharma to...
The Rose Sheet - December 12, 2018

Harvard Bioscience sells Denville Scientific to Thomas Scientific for $20mm
Harvard Bioscience Inc. sold Denville Scientific Inc. to Thomas Scientific LLC for $17mm up front and a $3mm earn-out.
Strategic Transactions - May 26, 2018
Back to the top Back to the top